Post-translational modifications of proteins take place during the aging of human lens. The present study describes a newly isolated glycation product of lysine, which was found in the human lens. Cataractous and aged human lenses were hydrolyzed and fractionated using reverse-phase and ion-exchange high performance liquid chromatography (HPLC). One of the nonproteinogenic amino acid components of the hydrolysates was identified as a 3-hydroxypyridinium derivative of lysine, 2-ammonio-6-(3-oxidopyridinium-1-yl)hexanoate (OP-lysine). The compound was synthesized independently from 3-hydroxypyridine and methyl 2-[(tert-butoxycarbonyl)amino]-6-iodohexanoate. The spectral and chromatographic properties of the synthetic OP-lysine and the substance isolated from hydrolyzed lenses were identical. HPLC analysis showed that the amounts of OP-lysine were higher in water-insoluble compared with water-soluble proteins and was higher in a pool of cataractous lenses compared with normal aged lenses, reaching 500 pmol/mg protein. The model incubations showed that an anaerobic reaction mixture of N ␣ -tertbutoxycarbonyllysine, glycolaldehyde, and glyceraldehyde could produce the N ␣ -t-butoxycarbonyl derivative of OP-lysine. The irradiation of OP-lysine with UVA under anaerobic conditions in the presence of ascorbate led to a photochemical bleaching of this compound. Our results argue that OP-lysine is a newly identified glycation product of lysine in the lens. It is a marker of aging and pathology of the lens, and its formation could be considered as a potential cataract risk-factor based on its concentration and its photochemical properties.Glycation is a natural process observed in living systems, consisting in post-translational modifications of the side chains of amino acids in proteins by reactive carbonyl components. Glycation is a multistage and multidirection process. Initially, so-called "early glycation products" are formed. At this stage the modifications of amino acids are reversible. Further reactions lead to the formation of advanced glycation end products (AGEs), 1 which are relatively stable and tend to accumulate in biological or model systems with time. AGEs are important from a medical point of view because their concentration increases during aging (1) or in different medical complications such as cataract formation (2), retinopathy (3), and nephropathy (4).A natural protective mechanism against glycation and other harmful post-translational modifications is protein turnover. The vast majority of protein molecules has a limited life span and is periodically degraded and rebuilt. A remarkable exception are the proteins in lens fiber cells, especially those in the lens nucleus, being as old as the individual to whom they belong. Thus, the lens is a very appropriate tissue to study the accumulation of AGEs in vivo.The characterization and quantification of AGEs are based on chemical, spectral, and immunological techniques. Two major types of experiments are used for this purpose: either the properties of the b...